BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 27806853)

  • 21. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.
    Loghavi S; Curry JL; Garcia-Manero G; Patel KP; Xu J; Khoury JD; Torres-Cabala CA; Nagarajan P; Aung PP; Gibson BR; Goodwin BP; Kelly BC; Korivi BR; Medeiros LJ; Prieto VG; Kantarjian HM; Bueso-Ramos CE; Tetzlaff MT
    J Cutan Pathol; 2017 Dec; 44(12):1075-1079. PubMed ID: 28885734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous myeloid dendritic cell dyscrasia: A cutaneous clonal monocytosis associated with chronic myeloproliferative disorders and peripheral blood monocytosis.
    Magro CM; Momtahen S; Verma S; Abraham RM; Friedman C; Nuovo GJ; Tam W
    Ann Diagn Pathol; 2016 Dec; 25():85-91. PubMed ID: 27806853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous extramedullary hemopoiesis in chronic myeloproliferative and myelodysplastic disorders.
    Haniffa MA; Wilkins BS; Blasdale C; Simpson NB
    J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S28-31. PubMed ID: 16843120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory Evaluation and Pathological Workup of Neoplastic Monocytosis - Chronic Myelomonocytic Leukemia and Beyond.
    El Hussein S; Khoury JD; Medeiros LJ; Loghavi S
    Curr Hematol Malig Rep; 2021 Jun; 16(3):286-303. PubMed ID: 33945086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
    Greenberg PL
    Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
    [No Abstract]   [Full Text] [Related]  

  • 27. Stem cell origin of human myeloid blood cell neoplasms.
    Fialkow PJ
    Verh Dtsch Ges Pathol; 1990; 74():43-7. PubMed ID: 1708632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and Molecular Approach to Adult-Onset, Neoplastic Monocytosis.
    Shallis RM; Siddon AJ; Zeidan AM
    Curr Hematol Malig Rep; 2021 Jun; 16(3):276-285. PubMed ID: 33890194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical myeloproliferative disorders: diagnosis and management.
    Tefferi A; Elliott MA; Pardanani A
    Mayo Clin Proc; 2006 Apr; 81(4):553-63. PubMed ID: 16610578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelodysplastic/myeloproliferative neoplasms.
    Cazzola M; Malcovati L; Invernizzi R
    Hematology Am Soc Hematol Educ Program; 2011; 2011():264-72. PubMed ID: 22160044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Histomorphologic findings of the bone marrow in chronic myeloproliferative diseases].
    Thiele J; Fischer R
    Z Hautkr; 1989 Oct; 64(10):903-4, 909-12. PubMed ID: 2686247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the bone marrow immune microenvironment in chronic myelomonocytic leukemia pathogenesis: novel mechanisms and insights into clonal propagation.
    Mangaonkar AA; Patnaik MM
    Leuk Lymphoma; 2022 Aug; 63(8):1792-1800. PubMed ID: 35377828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential Diagnosis and Workup of Monocytosis: A Systematic Approach to a Common Hematologic Finding.
    Mangaonkar AA; Tande AJ; Bekele DI
    Curr Hematol Malig Rep; 2021 Jun; 16(3):267-275. PubMed ID: 33880680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous involvement in Ph-negative myeloproliferative neoplasms: from extramedullary hematopoiesis to myeloid metastasis with histiocytic differentiation. A systematic review of the literature.
    Bonometti A
    Int J Dermatol; 2023 Oct; 62(10):1228-1236. PubMed ID: 37649236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myeloid Neoplasms.
    Subtil A
    Clin Lab Med; 2017 Sep; 37(3):575-585. PubMed ID: 28802501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indeterminate dendritic cell neoplasm of the skin: A 2-case report and review of the literature.
    Horna P; Shao H; Idrees A; Glass LF; Torres-Cabala CA
    J Cutan Pathol; 2017 Nov; 44(11):958-963. PubMed ID: 28880462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic workup in front of an adult monocytosis].
    Labrousse J; Pasini S; Vignon G; Bonnin A; Mottaz P; Carrere F; Augereau PF; Aucher P; Lellouche F
    Ann Biol Clin (Paris); 2019 Oct; 77(5):485-494. PubMed ID: 31486402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How I investigate monocytosis.
    Lynch DT; Hall J; Foucar K
    Int J Lab Hematol; 2018 Apr; 40(2):107-114. PubMed ID: 29345409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.